Affiliation:
1. Centro Nacional de Investigación Disciplinaria en Salud Animal, Instituto Nacional de Investigaciones Forestales Agrícolas y Pecuarias (INIFAP), Boulevard Cuauhnahuac No. 8534, Jiutepec 62550, Morelos, Mexico
2. Centro Nacional de Servicios de Constatación en Salud Animal SENASICA-SADER, Boulevard Cuauhnahuac No. 8534, Jiutepec 62550, Morelos, Mexico
Abstract
The expression of the Fasciola hepatica carboxylesterase type B (CestB) gene is known to be induced upon exposure to the anthelmintic triclabendazole (TCBZ), leading to a substantial rise in enzyme-specific activity. Furthermore, the nucleotide sequence of the CestB gene displays variations that can potentially result in radical amino acid substitutions at the ligand binding site. These substitutions hold the potential to impact both the ligand–protein interaction and the catalytic properties of the enzyme. Thus, the objective of our study was to identify novel CestB polymorphisms in TCBZ-resistant parasites and field isolates obtained from a highly endemic region in Central Mexico. Additionally, we aimed to assess these amino acid polymorphisms using 3D modeling against the metabolically oxidized form of the anthelmintic TCBZSOX. Our goal was to observe the formation of TCBZSOX-specific binding pockets that might provide insights into the role of CestB in the mechanism of anthelmintic resistance. We identified polymorphisms in TCBZ-resistant parasites that exhibited three radical amino acid substitutions at positions 147, 215, and 263. These substitutions resulted in the formation of a TCBZSOX-affinity pocket with the potential to bind the anthelmintic drug. Furthermore, our 3D modeling analysis revealed that these amino acid substitutions also influenced the configuration of the CestB catalytic site, leading to alterations in the enzyme’s interaction with chromogenic carboxylic ester substrates and potentially affecting its catalytic properties. However, it is important to note that the TCBZSOX-binding pocket, while significant for drug binding, was located separate from the enzyme’s catalytic site, rendering enzymatic hydrolysis of TCBZSOX impossible. Nonetheless, the observed increased affinity for the anthelmintic may provide an explanation for a drug sequestration type of anthelmintic resistance. These findings lay the groundwork for the future development of a molecular diagnostic tool to identify anthelmintic resistance in F. hepatica.
Subject
Infectious Diseases,Microbiology (medical),General Immunology and Microbiology,Molecular Biology,Immunology and Allergy
Reference32 articles.
1. Anthelmintic Resistance and Its Mechanism: A Review;Fissiha;Infect. Drug Resist.,2021
2. Understanding Triclabendazole Resistance;Brennan;Exp. Mol. Pathol.,2007
3. Recent Developments in the Epidemiology, Diagnosis, and Treatment of Fasciola Infection;Webb;Curr. Opin. Infect. Dis.,2018
4. Potential Economic Impact Assessment for Cattle Parasites in Mexico. Review;Grisi;Rev. Mex. Cienc. Pecu.,2017
5. Zumaquero-Ríos, J.L., Sarracent-Pérez, J., Rojas-García, R., Rojas-Rivero, L., Martínez-Tovilla, Y., Valero, M.A., and Mas-Coma, S. (2013). Fascioliasis and Intestinal Parasitoses Affecting Schoolchildren in Atlixco, Puebla State, Mexico: Epidemiology and Treatment with Nitazoxanide. PLoS Negl. Trop. Dis., 7.